Cyprium Therapeutics

New York, United States

Cyprium Therapeutics focuses on the development of novel therapies treatment for Menkes disease and related copper metabolism disorders.

$4.1M raised

Mar 2024

Grant

Biotechnology Health Care Medical Therapeutics

Top Investors

National Institute of Neurological Disorders and Stroke

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Cyprium Therapeutics

How much funding has Cyprium Therapeutics raised?

Cyprium Therapeutics has raised $4.1M in total funding. The most recent round was Grant. The last funding was announced in March 2024.

Who are Cyprium Therapeutics's investors?

Cyprium Therapeutics's investors include National Institute of Neurological Disorders and Stroke.

Where is Cyprium Therapeutics headquartered?

Cyprium Therapeutics is headquartered in New York, United States.

What does Cyprium Therapeutics do?

Cyprium Therapeutics focuses on the development of novel therapies treatment for Menkes disease and related copper metabolism disorders.

What stage is Cyprium Therapeutics at?

Cyprium Therapeutics is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 4, 2024.

MLA

"Cyprium Therapeutics — Funding & Investors." VCBacked, March 4, 2024, https://www.vcbacked.co/company/cyprium-therapeutics. Accessed July 3, 2026.

APA

VCBacked. (2024). Cyprium Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/cyprium-therapeutics

Wikipedia (cite web)

{{cite web |title=Cyprium Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/cyprium-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 4, 2024.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Vancouver$599K

Epsilogen

London$16.3M

Advanced Microbiome Interventions

Amsterdam$300K